News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|October 2, 2020

Best Practices for Motivational Pharmacotherapy Sessions

Author(s)Roberto Lewis-Fernández, MD, Angela A. Coombs, MD

These techniques may help promote self-efficacy and elicit patients’ commitment to resolve ambivalence about treatment.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

tinnitus bupropion psychiatry

Partially Reversible Tinnitus Associated with Bupropion: A Case Highlighting the Importance of Dosage Adjustment

ByMurtaza Khan, MD,James A. Bourgeois, OD, MD

February 10th 2026

antidepressants

Antidepressant Withdrawal Syndromes: Listening to the Patient and Taking It Slow

ByRonald W. Pies, MD,Jonathan F. Henssler, MD

February 10th 2026

antidepressants

Exiting Antidepressants: A Needed Spotlight on Withdrawal

ByNicolas Badre, MD,David Cohen, PhD,Camila Losada Strassle, JD

February 9th 2026

dementia lewy bodies zervimesine

Extension of Expanded Access Program for Zervimesine to Treat Dementia With Lewy Bodies

ByJessica Walters

February 5th 2026

pills

Increasing Prevalence of Long-Term Antidepressant Use in Australia: A Retrospective Observational Study

ByRobert M. Kaplan, MBChB, FRANZCP, MA, MPhil

February 5th 2026

Latest CME

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

Partially Reversible Tinnitus Associated with Bupropion: A Case Highlighting the Importance of Dosage Adjustment

OCD, Psychedelics, and Cannabinoids: New Evidence

Antidepressant Withdrawal Syndromes: Listening to the Patient and Taking It Slow

All the Medicines We Cannot Have

Denovo Biopharma Partners With Orygen for Phase 2 Study of Pomaglumetad Methionil in Treating Psychosis